Literature DB >> 36000602

Effectiveness of peripheral nerve blockage on the symptoms of both diseases in patients with fibromyalgia and chronic migraine coexistence.

Gokhan Evcili1, Ahmet Yabalak2.   

Abstract

OBJECTIVE: Peripheral nerve blockage treatments reduce central sensitization and are effective in patients with migraine. We wanted to evaluate the efficacy of peripheral nerve blockage in patients with fibromyalgia and migraine whose etiology may be responsible for central sensitization, and their associations are common.
METHODS: The files of patients with chronic migraine who had peripheral nerve blockage treatment in our clinic and had fibromyalgia were scanned. The patients underwent bilateral great occipital nerve, lesser occipital nerve, and supraorbital nerve blockage at baseline and in the second week. The revised Fibromyalgia Impact Questionnaire, Migraine Disability Assessment Scale, Visual Analog Scale scores, the number of days in pain, and the number of analgesics taken in the last month were recorded.
RESULTS: In the third month, Fibromyalgia Impact Questionnaire, Migraine Disability Assessment Scale, and Visual Analog Scale scores were significantly lower from baseline. While Fibromyalgia Impact Questionnaire scores in the third month were significantly lower than in the first month, no significant difference was observed between Visual Analog Scale scores. In the third month, the number of days in pain and the number of analgesics taken in the last month was significantly lower than the baseline but higher than the first month.
CONCLUSION: Peripheral nerve blockage has been found to be an effective treatment for the symptoms of both diseases in patients with migraine and fibromyalgia coexistence.

Entities:  

Mesh:

Year:  2022        PMID: 36000602      PMCID: PMC9574977          DOI: 10.1590/1806-9282.20220202

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


  22 in total

1.  Frequency of headache is related to sensitization: a population study.

Authors:  L Buchgreitz; A C Lyngberg; L Bendtsen; R Jensen
Journal:  Pain       Date:  2006-04-13       Impact factor: 6.961

2.  Fibromyalgia comorbidity in a community sample of adults with migraine.

Authors:  Dawn A Marcus; Amrita Bhowmick
Journal:  Clin Rheumatol       Date:  2013-06-07       Impact factor: 2.980

3.  Abnormal brain processing of cutaneous pain in migraine patients during the attack.

Authors:  Marina de Tommaso; Marco Guido; Giuseppe Libro; Luciana Losito; Vittorio Sciruicchio; Carlo Monetti; Francomichele Puca
Journal:  Neurosci Lett       Date:  2002-11-15       Impact factor: 3.046

Review 4.  Prevalence, clinical features and potential therapies for fibromyalgia in primary headaches.

Authors:  Marina de Tommaso
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

5.  Frequency of Migraine Headaches in Patients With Fibromyalgia.

Authors:  Brinder Vij; Mary O Whipple; Stewart J Tepper; Arya B Mohabbat; Mark Stillman; Ann Vincent
Journal:  Headache       Date:  2015-05-21       Impact factor: 5.887

6.  The prevalence of fibromyalgia in women aged 20-64 in Turkey.

Authors:  M Topbas; H Cakirbay; H Gulec; E Akgol; I Ak; G Can
Journal:  Scand J Rheumatol       Date:  2005 Mar-Apr       Impact factor: 3.641

7.  The effects of greater occipital nerve block and trigger point injection on brush allodynia and pain in migraine.

Authors:  Avi Ashkenazi; William B Young
Journal:  Headache       Date:  2005-04       Impact factor: 5.887

8.  Effectiveness of Greater Occipital Nerve Blocks in Migraine Prophylaxis.

Authors:  Nurten Inan; Levent E Inan; Özlem Coşkun; Tuğba Tunç; Mustafa Ilhan
Journal:  Noro Psikiyatr Ars       Date:  2016-03-01       Impact factor: 1.339

9.  Effects of treatment of peripheral pain generators in fibromyalgia patients.

Authors:  Giannapia Affaitati; Raffaele Costantini; Alessandra Fabrizio; Domenico Lapenna; Emmanuele Tafuri; Maria Adele Giamberardino
Journal:  Eur J Pain       Date:  2011-01       Impact factor: 3.931

Review 10.  Migraine prevalence. A review of population-based studies.

Authors:  W F Stewart; A Shechter; B K Rasmussen
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.